Final Program

282 TUESDAY • MAY 17
P1095
P1096
P1097
Expanding a National Program of Respiratory Health
Surveillance for Coal Miners—Update on the Implementation of
New Requirements for Coal Miner Health Surveillance in the
United States/C.N. Halldin, A.L. Wolfe, L.-A.F. Beeckman-Wagner,
D.J. Blackley, A.S. Laney, Morgantown, WV, p.A5449
Analysis on the Risk Factors of Greenhouse Farmer Lung in
Some Rural Areas of Liaoning Province/W. Xiaoge, Shenyang,
China, p.A5450
Environmental and Occupational Health (GEOHealth) Hub for
Eastern Africa: Review of Current State and Plans for Research
and Training/K. Berhane, A. Kumie, A. Afullo, L. Atuyambe, E.
Rugigana, N. Hundal, J. Samet, Los Angeles, CA, p.A5451
P1098 Silicon, a Potential Biomarker in Silicosis Research/H. Liu, X.
Hao, W. Tian, Z. Guo, S. Liu, Tangshan, China, p.A5452
P1099
P1100
C57
Building Conceptual Schema for Monitoring and Response
System on Occupational and Environmental Lung Disease/A.E.
Ozcelik, N. Ozcelik, Rize, Turkey, p.A5453
First-Time Monitoring of Simultaneous Effects of Hypergravity
on Heart and Lung by Electrical Impedance Tomography/J.B.
Borges, G. Hedenstierna, J.S. Bergman, C. Dussault, M.B.P.
Amato, S. Montmerle-Borgdorff, Uppsala, Sweden, p.A7885
THEMATIC POSTER SESSION
CELLULAR/MOLECULAR MECHANISMS AND
TRANSLATIONAL ASPECTS OF RESPIRATORY
INFECTIONS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area K, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1127
P1128
P1129
P1130
P1131
J.P. Mizgerd, ScD, Boston, MA
Disruption of Murine Lower Airway Microbiome/B.G. Wu, B.D.
Scaglione, J. Gilani, A. Wang, Y. Li, L. Segal, New York, NY, p.A5454
Dectin-1 Mediates the Induction and Processing of
Interleukin-1b by the Canonical NLRP3 Inflammasome in
B-Lymphocytes/M.F. Ali, A.G. Kronebusch, A.H. Limper, E.M.
Carmona, Rochester, MN, p.A5455
Thrombocytopenia and Lung Iron Content in Patients with
Pneumonia/K. Yaqub, K.K. Sakata, K. Williams, H. Vikram, L.
Wesselius, Scottsdale, AZ, p.A5456
Bacterial Killing of Cultured Pig Tracheal Epithelia Was Not
Altered by HCO3—Free Medium/S. Zhu, J.-H. Chen, Hong Kong
Prc, p.A5457
The Tie2-Agonist Vasculotide Protects Lungs from
Pneumonia-Induced Barrier Disruption/B. Gutbier, X. Jiang, C.
Ehrler, T.J. Mitchell, N. Weissmann, P. Van Slyke, D.J. Dumont, N.
Suttorp, M. Witzenrath, Berlin, Germany, p.A5458
P1132
P1133
Facilitator:
P1134
P1135
P1136
P1137
P1138
P1139
P1140
Facilitator:
Treatment with Synergistic TLR Ligands that Protect Against
Leukemia-Associated Pneumonias Does Not Worsen Tumor
Burden/H.H. Ware, M.M. Leiva-Juarez, C.T. Kirkpatrick, V.V.
Kulkarni, Y. Wang, S.E. Evans, Houston, TX, p.A5459
Mechanisms of Pyocyanin Toxicity and Genetic Determinants
of Resistance in Staphylococcus Aureus/M.J. Noto, W.J. Burns,
E.P. Skaar, Nashville, TN, p.A5460
C.S. Dela Cruz, MD, PhD, New Haven, CT
Comparison of an Anti-Alpha Toxin (AT) and Clumping Factor
A (ClfA) mAb Combination and Bi-Specific Antibodies for
Protection in S. Aureus Pneumonia/C. Tkaczyk, S.
Kasturirangan, M. Hamilton, A. Sadowska, Y.Y. Shy, G. Rainey, C.
Stover, B. Selllman, Gaithersburg, MD, p.A5461
Changes in Staphylococcal, Streptococcal and Pseudomonal
Growth and Pathogenicity During Fever/E. McEachern, A. Vyas,
J.H. Hwang, J. Joshua, L.E. Crotty Alexander, New York, NY,
p.A5462
Identification and Replication of Transcriptomic Biomarkers of
Bacterial Involvement in Lower Respiratory Tract Infections/S.
Bhattacharya, A. Rosenberg, D. Peterson, K. Grezesik, A. Baran,
J.M. Ashton, A. Corbette, J. Holden-Wiltse, T.J. Mariani, A. Falsey,
Rochester, NY, p.A5463
Celastrol Promotes Granulocyte Differentiation to Protect
Against Bacteria/K.L. Gates, P. Homan, Z. Lu, A.C.
McQuattie-Pimentel, F. Gonzalez, A.V. Misharin, N. Chandel, W.E.
Balch, R.I. Morimoto, G.S. Budinger, Chicago, IL, p.A5464
Obesity Worsens the Outcome of Influenza Virus Infection Via
Impaired IFN -Beta Induction and Reduced Expressions of
Antimicrobial Peptides in Mice/H. Namkoong, M. Ishii, H. Fujii, K.
Yagi, T. Asakura, S. Suzuki, H. Kamata, N. Hasegawa, T.
Betsuyaku, Tokyo, Japan, p.A5465
The Pulmonary OX40 Ligand Expression Induced by the
Influenza Infection Plays a Potential Role in the
Pathogenesis/T. Hirano, T. Kikuchi, N. Tode, H. Sugiura, M.
Ichinose, Sendai, Japan, p.A5466
Broccoli Sprout Homogenates and Live Attenuated Influenza
Virus: Effect on Peripheral Blood Natural Killer Cells/L. Muller,
M. Meyer, R.N. Bauer, H. Zhou, H. Zhang, S. Jones, C. Robinette,
T.L. Noah, I. Jaspers, Basel, Switzerland, p.A5467
Z.C. Chroneos, PhD, Hershey, PA
P1141 Nucleotide-Binding Oligomerization Domain Containing 2
(NOD2) Heterozygous Knock-Out Mice Are Protected from
Influenza A Virus Infection/K.M. Wiese, K.L. Staricha, K.M.
Ridge, Chicago, IL, p.A5468
P1142
Cyclic GMP-AMP Synthase (cGAS), Stimulator of Interferon
Genes (STING) and Interferon Activated Gene 16 (IFI16) Are
Essential for Intrinsic Lung Epithelial Responses Against
Influenza A Infection, but Not for Therapeutically Induced
Antiviral Resistance/V.V. Kulkarni, Y. Wang, C.T. Kirkpatrick,
M.M. Leiva-Juarez, A.K. Plumer, H.H. Ware, S.E. Evans, Houston,
TX, p.A5469
ATS 2016 • San Francisco